(Reuters) – Indian drugmaker Glenmark Pharmaceuticals said on Thursday it would sell a 75% stake in unit, Glenmark Life Sciences, to Nirma for 56.52 billion rupees ($679.84 million).
($1 = 83.1373 Indian rupees)
(Reporting by Ashna Teresa Britto)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content.